National Health Investors, Inc. (NYSE:NHI) Short Interest Update

National Health Investors, Inc. (NYSE:NHI) was the recipient of a large increase in short interest during the month of June. As of June 30th, there was short interest totaling 3,740,952 shares, an increase of 102.4% from the June 15th total of 1,847,936 shares. Approximately 7.9% of the shares of the company are sold short. Based on an average trading volume of 1,574,464 shares, the days-to-cover ratio is presently 2.4 days.

Insider Buying and Selling

In related news, CEO D. Eric Mendelsohn acquired 1,500 shares of the stock in a transaction that occurred on Friday, June 5th. The shares were bought at an average price of $68.84 per share, for a total transaction of $103,260.00. Following the completion of the transaction, the chief executive officer directly owned 133,316 shares in the company, valued at approximately $9,177,473.44. This trade represents a 1.14% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Robert A. Mccabe, Jr. bought 890 shares of the company’s stock in a transaction that occurred on Monday, June 15th. The stock was bought at an average price of $71.65 per share, for a total transaction of $63,768.50. Following the acquisition, the director directly owned 44,159 shares of the company’s stock, valued at $3,163,992.35. The trade was a 2.06% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders own 2.70% of the company’s stock.

Institutional Investors Weigh In On National Health Investors

A number of hedge funds have recently modified their holdings of NHI. Renaissance Group LLC boosted its position in shares of National Health Investors by 3.8% in the fourth quarter. Renaissance Group LLC now owns 3,206 shares of the real estate investment trust’s stock worth $245,000 after purchasing an additional 117 shares during the period. GAMMA Investing LLC raised its position in shares of National Health Investors by 41.8% during the 4th quarter. GAMMA Investing LLC now owns 461 shares of the real estate investment trust’s stock valued at $35,000 after purchasing an additional 136 shares during the period. Captrust Financial Advisors raised its position in shares of National Health Investors by 1.7% during the 4th quarter. Captrust Financial Advisors now owns 8,907 shares of the real estate investment trust’s stock valued at $680,000 after purchasing an additional 146 shares during the period. EverSource Wealth Advisors LLC lifted its stake in shares of National Health Investors by 34.3% during the 1st quarter. EverSource Wealth Advisors LLC now owns 626 shares of the real estate investment trust’s stock valued at $51,000 after buying an additional 160 shares in the last quarter. Finally, Assetmark Inc. lifted its stake in shares of National Health Investors by 13.5% during the 1st quarter. Assetmark Inc. now owns 1,356 shares of the real estate investment trust’s stock valued at $110,000 after buying an additional 161 shares in the last quarter. Institutional investors own 62.51% of the company’s stock.

National Health Investors Stock Performance

Shares of NHI traded down $0.35 on Wednesday, reaching $75.77. The company’s stock had a trading volume of 366,173 shares, compared to its average volume of 444,249. The stock’s 50 day simple moving average is $74.25 and its two-hundred day simple moving average is $79.59. The company has a debt-to-equity ratio of 0.83, a current ratio of 8.20 and a quick ratio of 8.20. The stock has a market capitalization of $3.67 billion, a P/E ratio of 24.44, a PEG ratio of 3.41 and a beta of 0.51. National Health Investors has a 12-month low of $67.94 and a 12-month high of $91.38.

National Health Investors Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, August 7th. Shareholders of record on Tuesday, June 30th will be given a $0.92 dividend. The ex-dividend date is Tuesday, June 30th. This represents a $3.68 annualized dividend and a yield of 4.9%. National Health Investors’s dividend payout ratio (DPR) is presently 118.71%.

Analyst Ratings Changes

A number of brokerages have weighed in on NHI. BMO Capital Markets decreased their target price on shares of National Health Investors from $90.00 to $80.00 and set an “outperform” rating for the company in a research note on Monday, June 15th. Cantor Fitzgerald restated an “overweight” rating and issued a $94.00 price target on shares of National Health Investors in a research note on Wednesday, April 22nd. Truist Financial cut their price objective on National Health Investors from $89.00 to $81.00 and set a “buy” rating for the company in a report on Friday, June 12th. Deutsche Bank Aktiengesellschaft cut their price objective on National Health Investors from $85.00 to $80.00 and set a “hold” rating for the company in a report on Thursday, June 25th. Finally, Wells Fargo & Company lowered their target price on National Health Investors from $84.00 to $79.00 and set an “equal weight” rating on the stock in a report on Monday, June 1st. Five analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $83.86.

National Health Investors Company Profile

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.